Today

Agents

Chat

Arena

Discover

More

App

Denali Therapeutics Q2 Operating Expenses USD 134.145 Million - DNLI News | Rallies

Denali Therapeutics Q2 Operating Expenses USD 134.145 Million

DNLI•2026-08-06

Q2 financial results

Aug. 6 (Reuters) - Denali Therapeutics Q2 net income was USD -127.553 million.

Q2 basic EPS: USD -0.68
Q2 operating income: USD -130.541 million
Q2 total revenue: USD 3.6 million

Related News

Innodata Q2 revenue rises 58%, beating estimates as customer base diversifies

INOD•2026-08-06

Clean Energy Fuels Q2 revenue rises but misses estimates

CLNE•2026-08-06

Biotech firm Prothena's Q2 net loss narrows on lower expenses

2026-08-06

Netflix director Richard N. Barton sells 2,160 shares for $162,216

NFLX•2026-08-06

Granite Ridge Resources declares quarterly dividend of $0.11 per share

GRNT•2026-08-06